Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 2840
TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382134(4-(4-((2-(4-(1-cyanocyclopropyl)phenyl)cyclohept-1...)
Affinity DataEC50:  275nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382136(US10273230, Compound of Example 22 | 4-(4-((2-(p-t...)
Affinity DataEC50:  275nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382131(4-(4-((2-(5,6,7,8-tetrahydronaphthalen-2-yl)cycloh...)
Affinity DataEC50:  275nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382129(4-(4-((4'-cyclopropyl-3,4,5,6-tetrahydro-[1,1'-bip...)
Affinity DataEC50:  275nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382134(4-(4-((2-(4-(1-cyanocyclopropyl)phenyl)cyclohept-1...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382133(4-(4-((2-(6-methoxypyridin-3-yl)cyclohex-1-en-1-yl...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382132(4-(4-([1,1'-bi(cyclohexane)]-1,1'-dien-2-ylmethoxy...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382139(US10273230, Compound of Example 50 | 4-(4-((2-(p-t...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382138(US10273230, Compound of Example 49 | 4-(4-((4-(5,6...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382137(US10273230, Compound of Example 48 | 4-(4-((4-(4-(...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382127(4-(4-((2-(4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)c...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382126(4-(4-((4'-(1-cyanocyclopropyl)-3,4,5,6-tetrahydro-...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382141(US10273230, Compound of Example 54 | 4-(4-((4-fluo...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382140(US10273230, Compound of Example 53 | 4-(4-((4'-(1-...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382130(4-(4-((2-(6-amino-5-(trifluoromethyl)pyridin-3-yl)...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM382128(4-(4-((4'-methoxy-3,4,5,6-tetrahydro-[1,1'-bipheny...)
Affinity DataEC50:  2.75E+3nMAssay Description:Beta (β) arrestin 2 Interaction Assay (BRET assay) was performed using CHO-K1 cells stably expressing the GPR120 receptor using β-galactosi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent